Journal of microbiology, epidemiology and immunobiologyJournal of microbiology, epidemiology and immunobiology0372-93112686-7613Central Research Institute for Epidemiology810.36233/0372-9311-2016-1-40-45SPECTRUM OF ANTIBIOTIC RESISTANCE AND PREVALENCE OF OXA-CARBAPENEMASES AMONG ACINETOBACTER BAUMANNII STRAINS, ISOLATED FROM PATIENTS OF SURGICAL AND REANIMATION DEPARTMENTS IN MOSCOWKryzhanovskayaO. A.noemail@neicon.ruLazarevaA. V.noemail@neicon.ruChebotarI. V.noemail@neicon.ruBocharovaYu. A.noemail@neicon.ruMayanskyN. A.noemail@neicon.ruScientific Centre of Children’s Health28022016931404510042019Copyright © 2016, Kryzhanovskaya O.A., Lazareva A.V., Chebotar I.V., Bocharova Y.A., Mayansky N.A.2016Aim. Characterize spectrum of antibiotics resistance of Acinetobacter baumannii strains, isolated from patients of 8 surgical and reanimation departments of 3 medical institution of Moscow, and determine molecular-genetic mechanisms of stability of their carbapenem-resistant forms. Materials and methods. 95 strains of A. baumannii, isolated from patients of reanimation and surgical departments of Moscow in 2012 - 2014, were studied. Sensitivity of strains to antibiotics was tested phenotypically according to recommendations of EUCAST. The presence ofVIM, IMP, OXA-23, OXA-40, OXA-48, OXA-58 and NDM genes in the studied strains was determined by polymerase chain reaction in real time. Results. 86.3% of strains turned out to be non-sensitive to carbapenems, sensitive - 13.7%. 80.0% of strains were non-sensitive to gentamicin, 80.0% of strains - to netilmicin, 94.7% of strains - to ciprofloxacin, 2.1% - to colistin. 91.6% of isolates have shown non-sensitivity to members of 2 and more classes of antibiotics, 78.9% of strains - to members of 3 classes. 2 strains were panresistant, 4.2% (4/95) of the isolates were sensitive to all the classes of antibiotics. Metallo-P-lactamases were not detected. Genes of carbapenemases (OXA-23 and/or OXA-40) were detected in 85.3% (81/95) of strains, characterized phenotypically as non-sensitive to carbapenems. Conclusion. The results obtained shown an increase of resistance to carbapenems and multiple resistance in clinically significant strains of A. baumannii. Resistance to carbapenems is associated with OXA-23 and OXA-40 genes. The conclusions allow to justify perspectives of introduction of technologies of molecular-genetic testing of antibiotics resistance.Acinetobacter baumanniiAcinetobacter baumanniiantibioticsresistancecarbapenemase genesантибиотикирезистентностьгены карбапенемаз[Горбич Ю.Р., Карпов И.А., Мартинович А.А., Левшина Н.Н. Особенности резистентности Acinetobacter baumannii к карбапенемам в Республике Беларусь. Здравоохранение. 2011, 5: 25-30.][Дьячкова В.С., Бажукова Т.А. Механизмы резистентности микроорганизмов к в-лактамным антибиотикам. Журн. микробиол. 2014, 4: 101-109.][Решедько Г. К., Рябкова Е. Л., Кречикова О. И., Сухорукова М. В., Шевченко О. В., Эйдельштейн М. В., Козлов Р.С. Резистентность к антибиотикам грамотрицательных возбудителей нозокомиальных инфекций в ОРИТ многопрофильных стационаров России. Клин. микробиол. антимикроб. химиотер. 2008, 10: 96-112.][Руднов В. А., Бельский Д.В., Дехнич А.В. Инфекции в ОРИТ России: результаты национального многоцентрового исследования. Клин. микробиол. антимикроб. химиотер. 2011, 13: 4: 294-304.][Чеботарь И.В., Лазарева А.В., Масалов Я.К., Михайлович В.М., Маянский Н.А. Acinetobacter: микробиологические, патогенетические и резистентные свойства. Вестн. РАМН. 2014, 9-10: 39-50.][Шевченко О. В., Эйдельштейн М. В., Степанова М. Н. Металло-Р-лактамазы: значение и методы выявления у грамотрицательных неферментирующих бактерий. Клин. микробиол. антимикроб. химиотер. 2007, 1: 211-218.][Cornaglia G., Giamarellou H., Rossolini G. M. Metallo-P-lactamases: a last frontier for P-lactams? Lancet Infect. Dis. 2011, 11 (5): 381-393.][Custovic A., Smajlovic J., Hadzic S. et al. Epidemiological surveillance of bacterial nosocomial infections in the surgical intensive care unit. Materia socio-medica. 2014, 26 (1): 7-11.][Falagas M.E., Koletsi P.K., Bliziotis I.A. The diversity of definitions of multidrug-resistant (MDR) and pandrug-resistant (PDR) Acinetobacter baumannii and Pseudomonas aeruginosa. J. Med. Microbiol. 2006, 55 (12): 1619-1629.][Fleiss J.L. Statistical methods for rates and proportions. John Wiley & Sons Inc., New Ybrk, 1981.][Fritsche T.R., Sader H.S., Toleman M.A. et al. Emerging metallo-P-lactamase-mediated resistances: a summary report from the worldwide SENTRY antimicrobial surveillance program. Clin. Infect. Dis. 2005, 41 (Suppl. 4): S276-S278.][Higgins P.G., Dammhayn C., Hackel M., Seifert H. Global spread of carbapenem-resistant Acinetobacter baumannii. J. Antimicrob. Chemother. 2010, 65 (2): 233-238.][Kempf M., Rolain J.M. Emergence of resistance to carbapenems in Acinetobacter baumannii in Europe: clinical impact and therapeutic options. Int. J. Antimicrob. Agents. 2012, 39 (2): 105-114.][Maragakis L.L, Perl T.M. Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options. Clin. Infect. Dis. 2008, 46 (8): 1254-1263.][Perez F., Hujer A. M., Hujer K. M. et al. Global challenge ofmultidrug-resistant Acinetobacter baumannii. Antimicrob. Аgents Сhemotherapy. 2007, 51 (10) : 3471-3484][Tamayo-Legorreta E.M., Garza-Ramos U., Barrios-Camacho H. et al. Identification of OXA-23 carbapenemases: novel variant OXA-239 in Acinetobacter baumannii ST758 clinical isolates in Mexico. New Microbes New Infect. 2014, 2 (6): 173-174.][Zarrilli R., Pournaras S., Giannouli M., Tsakris A. Global evolution of multidrug-resistant Acinetobacter baumannii clonal lineages. Int. J. Antimicrob. Agents. 2013, 41 (1): 11-19.]